RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 108 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 4.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $181,000 | -35.1% | 76,149 | 0.0% | 0.00% | – |
| Q3 2016 | $279,000 | +64.1% | 76,149 | 0.0% | 0.00% | – |
| Q2 2016 | $170,000 | +7.6% | 76,149 | 0.0% | 0.00% | – |
| Q1 2016 | $158,000 | -31.6% | 76,149 | 0.0% | 0.00% | – |
| Q4 2015 | $231,000 | +29.8% | 76,149 | +5.7% | 0.00% | – |
| Q3 2015 | $178,000 | -22.9% | 72,065 | 0.0% | 0.00% | – |
| Q2 2015 | $231,000 | +122.1% | 72,065 | +147.7% | 0.00% | – |
| Q1 2015 | $104,000 | -79.9% | 29,091 | -87.2% | 0.00% | – |
| Q4 2014 | $517,000 | -55.4% | 227,922 | -61.9% | 0.00% | -100.0% |
| Q3 2014 | $1,160,000 | -44.6% | 598,253 | +3.8% | 0.00% | 0.0% |
| Q2 2014 | $2,092,000 | +227.4% | 576,293 | +249.7% | 0.00% | – |
| Q1 2014 | $639,000 | +34.8% | 164,781 | -0.8% | 0.00% | – |
| Q4 2013 | $474,000 | -20.3% | 166,152 | 0.0% | 0.00% | – |
| Q3 2013 | $595,000 | +26.6% | 166,152 | +18.3% | 0.00% | – |
| Q2 2013 | $470,000 | – | 140,480 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 1,847,087 | $4,119,000 | 3.26% |
| Sio Capital Management, LLC | 1,333,696 | $2,974,000 | 1.52% |
| Boxer Capital, LLC | 700,000 | $1,561,000 | 1.38% |
| Palo Alto Investors LP | 5,386,534 | $12,012,000 | 0.91% |
| ACUTA CAPITAL PARTNERS, LLC | 747,748 | $1,667,000 | 0.80% |
| SENZAR ASSET MANAGEMENT, LLC | 1,443,003 | $3,217,897,000 | 0.70% |
| Ghost Tree Capital, LLC | 800,000 | $1,784,000 | 0.52% |
| NEA Management Company, LLC | 3,243,150 | $7,232,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 850,000 | $1,896,000 | 0.34% |
| Rock Springs Capital Management LP | 1,750,000 | $3,903,000 | 0.29% |